http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-077861-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e17ac3e790b960c8a589610fa3d767e6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-92
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-342
filingDate 2010-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75bb769d3e792849d8460a47746a3b8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6802546bcb43a884c13adf3e5554afbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_300464d7f5f7b9ca7cb382a4e5c19a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54704a75714511342c0888eafa1321ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_220ac22e48fa8602cf131e3ae0166521
publicationDate 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-077861-A1
titleOfInvention ORAL CARE COMPOSITION INCLUDING A SESQUITERPENOID AND AN ANTIMICROBIAL AGENT
abstract Oral care compositions and use of such oral care compositions for the treatment of conditions caused by biofilm formation. Methods to inhibit the formation and / or degradation of the biofilm. The oral care composition includes a sesquiterpenoid and a microbial agent, in which sesquiterpenoid e and the antimicrobial agent are present in an amount effective to inhibit and / or degrade a biofilm in an oral cavity. Claim 3: The oral care composition according to claim 1, characterized in that sesquiterpenoid is selected from the group consisting of nerolidol, farnesol, bisabolol, apritone, and mixtures thereof. Claim 6: An oral composition according to any of the preceding claims, characterized in that the antimicrobial agent is selected from Triclosan, pyridinium cetyl chloride, magnolia extract, magnolol, honokiol, magnolol butyl, honokiol propyl, chloride zinc, zinc lactate, zinc citrate, stannous fluoride and stannous chloride.
priorityDate 2009-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408068020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131864324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448069540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450465323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21267029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5356544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450338722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448924711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61436

Total number of triples: 53.